| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 01/05/2005 | CN1183129C Condensed azepines as vasporession agonists |
| 01/05/2005 | CN1182844C Use of dialkylfumarates |
| 01/04/2005 | US6838584 Estrogen receptor modulators |
| 01/04/2005 | US6838574 Induction cell differentiation; leukemia therapy |
| 01/04/2005 | US6838559 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease |
| 01/04/2005 | US6838274 Urocortin proteins and uses thereof |
| 01/04/2005 | US6838253 Using an enzyme inhibitor of 11 beta -reductase; administering carbenoxolone |
| 01/04/2005 | CA2301503C Pharmaceutical compositions for oral administration of molecular iodine |
| 12/30/2004 | US20040266884 Compounds for blocking androgen receptors |
| 12/30/2004 | US20040266856 Biaryloxymethylarenecarboxylic acids as glycogen synthase activator |
| 12/30/2004 | US20040266833 Novel use of certain insulin sensitizers or ppar-gamma agonists |
| 12/30/2004 | US20040266830 Insulin sensitivity enhancer and second antidiabetic of different mechanism; suppressing hyperglycemia |
| 12/30/2004 | US20040266820 quinolin-2-ones and chromen-2-ones compounds that have been derivatized at the 6-position with a urea or thiourea derivative; used as androgen antagonists; kits |
| 12/30/2004 | US20040266799 Corticotropin-releasing factor (CRF); such as 4-chloro-2-methyl-5-nitro-8-(2,4-dichloro)phenyl-1,7-naphthyridine for treating stroke, anxiety, depression, and/or irritable bowel syndrome |
| 12/30/2004 | US20040266773 Such as 4-(3-methoxyphenyl)-5-methyl-6-(2-fluorobenzyl)-2-(N-(2-pyridyl)ethyl-N -methyl)ethyl-pyridazin-3-one; drugs/prodrugs for treatment of sex-hormone related conditions in men/women |
| 12/30/2004 | US20040266745 Estrogen-gestagen combination preparations and uses thereof |
| 12/30/2004 | US20040266720 Splice-region antisense composition and method |
| 12/30/2004 | US20040266695 Novel LHRH antagonists having improved solubility properties |
| 12/30/2004 | US20040266678 Methods and compositions for treating polycystic ovary syndrome |
| 12/30/2004 | US20040265972 Modified human chorionic gonadotropin (CG) for use in treatment and prevention of metabolic and reproductive diseases |
| 12/30/2004 | US20040265971 Cytokine for use in stem cell propagation and treatment ot cardiovascular, bone, nervous system and inflammatory disorders |
| 12/30/2004 | US20040265968 Tissue plasminogen activator-like protease |
| 12/30/2004 | US20040265807 Enzymes |
| 12/30/2004 | US20040265386 Gel compositions |
| 12/30/2004 | US20040265380 Orodispersible effervescent tablets |
| 12/30/2004 | US20040265299 Comprising dextrin, starch, peach resin and magnesium stearate; use in hyperthyroidism therapy; reduce serum thyroid hormones level by binding thyroid hormones which is excreted to intestinal tract; hormone inhibitors |
| 12/29/2004 | WO2004113562A1 Method for assaying lkb1 phosphorylation activity |
| 12/29/2004 | WO2004113344A1 Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same |
| 12/29/2004 | WO2004113309A1 Thiazoline derivatives as selective androgen receptor modulators (sarms) |
| 12/29/2004 | WO2004113300A1 Novel tricyclic heterocycle compound |
| 12/29/2004 | WO2004113282A1 Therapeutic agents |
| 12/29/2004 | WO2004112904A1 Medicament comprising plant material from mascagnia eggersiana for treating type 2 diabetes mellitus |
| 12/29/2004 | WO2004112827A1 Sustained-release fine granular preparation of human growth hormone and process for producing the same |
| 12/29/2004 | WO2004112822A1 Synthetic peptide combinations and methods for the production thereof |
| 12/29/2004 | WO2004112817A1 Extract from plant of japanese parsley family and process for producing the same |
| 12/29/2004 | WO2004112803A1 Methods of managing the symptoms of premenstrual syndrome |
| 12/29/2004 | WO2004112511A2 Supplement for restoring growth hormone levels |
| 12/29/2004 | WO2003082370A3 Transcellular drug delivery system |
| 12/29/2004 | WO2003015797A8 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine |
| 12/29/2004 | WO2002043648A3 Compounds active at the glucocorticoid receptor ii |
| 12/29/2004 | EP1491524A2 Selective androgen receptor modulators and methods of use thereof |
| 12/29/2004 | EP1491236A1 Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same |
| 12/29/2004 | EP1491192A1 Biological activity-promoting compositions containing soybean germ-origin isoflavone aglycon |
| 12/29/2004 | EP1490406A1 Costimulatory molecule and its use |
| 12/29/2004 | EP1490393A1 11beta-substituted 19-nor-17alpha-pregna-1,3,5(10)-trien-17beta-ols with a 21,16alpha-lactone ring |
| 12/29/2004 | EP1490341A1 Novel adamantane derivatives |
| 12/29/2004 | EP1490339A1 Novel chalcone derivatives and uses thereof |
| 12/29/2004 | EP1490338A1 Use of an alfa2-adrenoreceptor antagonist for cns-related diseases |
| 12/29/2004 | EP1490335A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 12/29/2004 | EP1490317A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/29/2004 | EP1490070A2 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
| 12/29/2004 | EP1490065A1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors |
| 12/29/2004 | EP1490062A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/29/2004 | EP1490060A1 Antidiabetic agents |
| 12/29/2004 | EP1379140A4 Production of pancreatic islet cells and delivery of insulin |
| 12/29/2004 | EP1204646B1 1,4,5,6 -tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 12/29/2004 | EP1135123B1 Use of isatin derivatives as ion channel activating agents |
| 12/29/2004 | EP1123084B1 Use of testosterone esters and/or testosterone for producing bucally applicable bio-adhesive systems with time-released active ingredients |
| 12/29/2004 | EP0986545B1 Non-steroidal (hetero) cyclically substituted acylanilides with mixed gestagen and androgen activity |
| 12/29/2004 | EP0885211B1 Compounds with a sulfamate group |
| 12/29/2004 | CN1558946A New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 12/29/2004 | CN1558905A Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 12/29/2004 | CN1558762A Novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer |
| 12/29/2004 | CN1557449A Chinese traditional medicine for treating hyperthyroidism |
| 12/29/2004 | CN1557376A Medicinal composition for treating hyperthyroidism |
| 12/29/2004 | CN1557324A Use of ecdysterone in preparation of insulin resistance medicine |
| 12/29/2004 | CN1557292A Formulation for improving human growth hormone release and its uses |
| 12/29/2004 | CA2530036A1 Medicament, in particular for the treatment of diabetes mellitus type 2 |
| 12/29/2004 | CA2529317A1 Supplement for restoring growth hormone levels |
| 12/29/2004 | CA2529297A1 Therapeutic agents |
| 12/29/2004 | CA2527085A1 Synthetic peptide combinations and methods for the production thereof |
| 12/29/2004 | CA2524256A1 Sustained-release fine granular preparation of human growth hormone and process for producing the same |
| 12/28/2004 | US6835751 Bicyclic amino acids as pharmaceutical agents |
| 12/28/2004 | US6835749 Sulfohydroxamic acids and sulfohydroxamates and their use as MEK inhibitors |
| 12/28/2004 | US6835731 Chemokine receptor binding heterocyclic compounds |
| 12/28/2004 | US6835729 2-phenyl-1-[4(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 12/28/2004 | US6835372 Mixtures of di-(tri)peptides and drugs such as cyclosporin used as aerosols; drug delivery |
| 12/23/2004 | WO2004111038A1 5,6-bis (4-chlorophenyl)-n-piperidin1-yl-3-(piperidin-1-yl-carbonyl)pyrazine-2-carboxamide |
| 12/23/2004 | WO2004111033A1 2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator. |
| 12/23/2004 | WO2004111019A2 Protective groups cleavable by serumal albumins |
| 12/23/2004 | WO2004111012A1 Imidazolidine derivative |
| 12/23/2004 | WO2004110983A2 New benzamides as pparϒ modulators |
| 12/23/2004 | WO2004110454A1 COMPOSITION FOR TREATMENT FOR OR PREVENTION OF DISEASE NECESSITATING ADMINISTRATION OF ADENOSINE A2a RECEPTOR AGONIST |
| 12/23/2004 | WO2004110408A2 Process for the manufacture of stable shaped particles consisting of estradiol and cholesterol |
| 12/23/2004 | WO2004089917A3 Process for resolving 2,4-diamino-3,6-dihydro-1,3,5-triazines, useful for the treatment of disorders associated with insulin resistance syndrome |
| 12/23/2004 | US20040259925 Pharmaceutical compositions and methds for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases |
| 12/23/2004 | US20040259902 Dipeptidyl aminopeptidase inhibitors; antidiabetic agents for type 2 diabetes; 2-amino-3-(substituted phenyl-, pyridyl- or pyrrolyl-)-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinoline compounds |
| 12/23/2004 | US20040259890 trans-3'-oxo-N-(trans-4-phenylcyclohexyl)-spiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-carboxamide e.g.; neuropeptide Y receptor antagonists for treatment of bulimia, obesity or diabetes for example |
| 12/23/2004 | US20040259886 Compositions and methods for treating osteoporosis and lowering cholesterol |
| 12/23/2004 | US20040259879 Antiarthritic agents; colon cancer, neurodegenerative agents |
| 12/23/2004 | US20040259864 Substituted pyrimidinone derivatives as ligands of integrin receptors |
| 12/23/2004 | US20040259849 17Alpha-hydroxy-14Beta-steroids with hormonal effect |
| 12/23/2004 | US20040258689 Augmenting activin induced signaling in cells; screening for complex inhibitors; treatment of reproductive, developmental, skin, bone, hepatic, hematopoietic and/or central nervous system disorders; prostrate cancer |
| 12/23/2004 | DE10255242A9 Verfahren zur Reinigung von Liponsäure A process for purifying lipoic acid |
| 12/23/2004 | CA2849228A1 Process for the manufacture of stable shaped particles consisting of estradiol and cholesterol |
| 12/23/2004 | CA2528545A1 Process for the manufacture of stable shaped particles consisting of estradiol and cholesterol |
| 12/23/2004 | CA2528231A1 New benzamides as ppar.gamma. modulators |
| 12/23/2004 | CA2527033A1 2-substitued 5,6-diaryl-pyrazine derivatives as cb1 modulators |
| 12/22/2004 | EP1489088A1 Novel alpha-amino-n-(diaminophosphinyl)lactam derivative |
| 12/22/2004 | EP1488807A1 Remedies for sex hormone-dependent disease |